Hancock Whitney’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,007
Closed -$228K 755
2025
Q4
$228K Hold
5,007
﹤0.01% 728
2025
Q3
$212K Buy
+5,007
New +$189K ﹤0.01% 746
2017
Q2
Sell
-525,710
Closed -$8.75M 548
2017
Q1
$8.75M Sell
525,710
-210
-0% -$3.71K 0.36% 132
2016
Q4
$10.1M Sell
525,920
-1,100
-0.2% -$20K 0.37% 124
2016
Q3
$9.26M Buy
+527,020
New +$7.97M 0.37% 122

Other funds holding AORT

Hancock Whitney's AORT Position: Q1 2026 in Review

Hancock Whitney sold out of Artivion (AORT) in Q1 2026, closing a stake of 5,007 shares — an estimated $228K sold.

Hancock Whitney first reported a position in AORT in Q3 2016 and held it in 5 quarters. The position peaked at $10.1M in Q4 2016. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Hancock Whitney reported no remaining Artivion position as of Q1 2026 after selling out during the quarter.
  • Hancock Whitney sold 5,007 Artivion shares in Q1 2026, an estimated $228K.
  • Hancock Whitney first reported a position in Artivion in Q3 2016 and held it in 5 quarters.
  • Hancock Whitney's Artivion position peaked at $10.1M in Q4 2016.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.